A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the efficacy of thalidomide for the
treatment of anemia in patients with myelodysplastic syndromes (MDS).